Literature DB >> 23207161

Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.

Yong Huang1, Feng-Mei Wang, Tao Wang, Yi-Jun Wang, Zheng-Yan Zhu, Ying-Tang Gao, Zhi Du.   

Abstract

PURPOSE: Tumor-infiltrating lymphocytes are considered to represent a host immune response against tumor. This study was carried out to analyze the effect of both FoxP3+ regulatory T cells (Tregs) and CD8+ T lymphocytes in prognostic value of hepatocellular carcinoma (HCC) patients.
METHODS: Expressions of FoxP3, CD4, CD8 and CD34 in patient-matched tumors and peritumoral tissues were assessed by immunohistochemistry for 54 HCC patients. The prognostic effect of groups with high and low numbers was evaluated by the Kaplan-Meier and Cox model analysis using median values as a cutoff.
RESULTS: Compared with the corresponding peritumoral tissue, the density of intratumoral Tregs was significantly higher, while the density of intratumoral CD8+ T cells was lower (p < 0.001 and p = 0.013, respectively). In addition, tumor-infiltrating Tregs were positively correlated with microvessel density in tumors (r = 0.334, p = 0.020). The high intratumoral Tregs density group showed a significantly lower survival rate (overall survival, p = 0.018; disease-free survival, p = 0.029). Multivariate Cox analysis revealed that intratumoral Tregs density was an independent prognostic factor for HCC.
CONCLUSIONS: Tumor-infiltrating Tregs may promote HCC progression by fostering angiogenesis and decreasing CD8+ T cells. High tumor-infiltrating Tregs are thought to be an unfavorable prognostic indicator for HCC.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23207161     DOI: 10.1159/000342801

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  38 in total

1.  Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors.

Authors:  Tina C Albershardt; Jardin Leleux; Andrea J Parsons; Jordan E Krull; Peter Berglund; Jan Ter Meulen
Journal:  NPJ Vaccines       Date:  2020-06-16       Impact factor: 7.344

Review 2.  Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma.

Authors:  Ai-Bin Zhang; Yi-Gang Qian; Shu-Sen Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2016 Dec.       Impact factor: 3.066

3.  [Th1/Th2 and Treg/Th17 cell balance in peripheral blood of patients with ovarian cancer].

Authors:  Li-Hua Wang; Liang-Liang Wang; Jing Zhang; Pei Zhang; Sheng-Ze Li
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

4.  Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.

Authors:  Su-Jin Shin; Sang Yong Kim; Yoon Young Choi; Taeil Son; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh; Chung-Gyu Park; Hyoung-Il Kim
Journal:  Oncologist       Date:  2019-03-20

Review 5.  Immunotherapy for hepatocellular carcinoma: From basic research to clinical use.

Authors:  Yu-Peng Hong; Zi-Duo Li; Pankaj Prasoon; Qi Zhang
Journal:  World J Hepatol       Date:  2015-05-08

6.  Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.

Authors:  Alissa A Thomas; Jan L Fisher; Gilbert J Rahme; Thomas H Hampton; Udo Baron; Sven Olek; Tim Schwachula; C Harker Rhodes; Jiang Gui; Laura J Tafe; Gregory J Tsongalis; Joel A Lefferts; Heather Wishart; Jonathan Kleen; Michael Miller; Chery A Whipple; Francine B de Abreu; Marc S Ernstoff; Camilo E Fadul
Journal:  Neuro Oncol       Date:  2015-01-24       Impact factor: 12.300

Review 7.  Immunosuppression in liver tumors: opening the portal to effective immunotherapy.

Authors:  P Guha; J Reha; S C Katz
Journal:  Cancer Gene Ther       Date:  2016-12-02       Impact factor: 5.987

8.  Screening potential prognostic biomarkers for portal vein emboli in patients with hepatocellular carcinoma.

Authors:  Weijie Zhou; Da Lang Fang; Yongfei He
Journal:  J Gastrointest Oncol       Date:  2021-08

9.  On the Prognostic Power of Tumor-Infiltrating Lymphocytes - A Critical Commentary.

Authors:  Zeev Elkoshi
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

10.  Leukocytes infiltration correlates intratumoral microvessel density and influence overall and late-phase disease-free survival in hepatocellular carcinoma.

Authors:  Yuan Yang; Ning Fu; Haiqing Wang; Jingcheng Hao
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.